Trial
NCT03520686
Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
Non Small Cell Lung Cancer
Intervention
NAI + Pembrolizumab
Why stopped
There are no longer active subjects on QUILT-2.023. Data will be entered into clinicaltrials.gov within 1 year of the primary completion date.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-26